Literature DB >> 30763192

Brazil's Fight against Hepatitis C - Universalism, Local Production, and Patents.

Elize M da Fonseca1, Kenneth Shadlen1, Francisco I Bastos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30763192     DOI： 10.1056/NEJMp1812959

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  Hepatitis C elimination: a Public Health Perspective.

Authors:  Radha K Dhiman; Gagandeep S Grover; Madhumita Premkumar
Journal:  Curr Treat Options Gastroenterol       Date:  2019-09

Review 2.  Unblocking Barriers of Access to Hepatitis C Treatment in China: Lessons Learned from Tianjin.

Authors:  Peiwen Zhang; Ran Guo; Jun Lian; Mengjia Zhi; Chengzhen Lu; Weishen Wu; Lihong Wang; Polin Chan; Zhongdan Chen; Jing Sun
Journal:  Ann Glob Health       Date:  2020-04-06       Impact factor: 2.462

3.  Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis.

Authors:  Hugo Perazzo; Rodolfo Castro; Paula M Luz; Mariana Banholi; Rafaela V Goldenzon; Sandra W Cardoso; Beatriz Grinsztejn; Valdilea G Veloso
Journal:  Bull World Health Organ       Date:  2019-11-08       Impact factor: 9.408

4.  Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis.

Authors:  Michael J Zoratti; Ayesha Siddiqua; Rita E Morassut; Dena Zeraatkar; Roger Chou; Judith van Holten; Feng Xie; Eric Druyts
Journal:  EClinicalMedicine       Date:  2020-01-05

5.  Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis.

Authors:  Maryam Sadeghimehr; Barbara Bertisch; Francesco Negro; Maia Butsashvili; Sonjelle Shilton; Irina Tskhomelidze; Maia Tsereteli; Olivia Keiser; Janne Estill
Journal:  PeerJ       Date:  2021-09-10       Impact factor: 2.984

Review 6.  Unlocking Access To Novel Medicines In China-A Review From A Health System Perspective.

Authors:  Yifan Diao; Mingshuang Li; Zhiran Huang; Jing Sun; Yoke Ling Chee; Yunali Liu
Journal:  Risk Manag Healthc Policy       Date:  2019-12-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.